25 September 2006

Sung Hoon Yang, Kyung‐Suk Suh, Hae Won Lee, Eung‐Ho Cho, Jai Young Cho, Yong Beom Cho, Nam‐Joon Yi, Kuhn Uk Lee – 8 September 2006 – Positron emission tomography (PET) using F‐18 fluoro‐2‐deoxy‐d‐glucose (18F‐FDG) is now well established as a noninvasive diagnostic tool for the detection of a variety of malignant tumors. However, in the case of hepatocellular carcinoma (HCC), several investigators have reported controversial conclusions and an inadequate sensitivity for PET (50‐55%).

Thomas Decaens, Françoise Roudot‐Thoraval, Solange Hadni‐Bresson, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre‐Henri Bernard, Olivier Boillot, Laurent Sulpice, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges‐Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Cherqui, Christophe Duvoux – 8 September 2006 – Orthotopic liver transplantation (OLT) indication for hepatocellular carcinoma (HCC) is currently based on the Milan criteria.

Giuseppe Fusai, Parveen Dhaliwal, Nancy Rolando, Caroline Anne Sabin, David Patch, Brian Ritchie Davidson, Andrew Kenneth Burroughs, Keith Rolles – 1 September 2006 – Predictive factors for intrahepatic cholestasis after orthotopic liver transplantation (OLT) have not yet been established. We sought to identify the incidence and risk factors associated with prolonged severe intrahepatic cholestasis (PSIC) after OLT. We assessed 428 consecutive patients undergoing their first OLT.

George N. Ioannou – 1 September 2006 – This study aimed to develop and validate a comprehensive model that predicts survival after liver transplantation based on pretransplant donor and recipient characteristics. Complete data were available from the United Network for Organ Sharing for 20,301 persons who underwent liver transplantation in the United States between 1994 and 2003. Proportional‐hazards regression was used to identify the donor and recipient characteristics that best predicted survival and incorporate these characteristics in a multivariate model.

Tilak U. Shah, Richard C. Semelka, Vasilis Voultsinos, Jorge Elias Jr., Ersan Altun, Ertan Pamuklar, Zeynep Firat, David A. Gerber, Jeffrey Fair, Mark W. Russo – 1 September 2006 – The detection of main portal vein thrombosis (PVT) on preoperative imaging of liver transplant candidates has important technical implications for the transplantation procedure. Data are scarce regarding the accuracy of magnetic resonance imaging (MRI) at detecting PVT. The aim of our study was to compare preoperative findings of the portal vein on MRI to operative findings at liver transplantation.

Stuart A. McCluskey, Keyvan Karkouti, Duminda N. Wijeysundera, Karen Kakizawa, Mohammed Ghannam, Ahmed Hamdy, David Grant, Gary Levy – 1 September 2006 – Massive blood transfusion (MBT) remains a serious and common occurrence in liver transplantation surgery. This retrospective cohort study was undertaken to identify preoperative predictors of MBT and to develop a risk index for MBT in liver transplantation. Data were retrospectively collected on all liver transplantations carried out at a single institution between January 1998 and March 2004.

Patrizia Farci – 29 August 2006

Nicholas F. LaRusso, Benjamin L. Shneider, Dennis Black, Gregory J. Gores, Stephen P. James, Edward Doo, Jay H. Hoofnagle – 29 August 2006 – Primary sclerosing cholangitis (PSC) is a rare but important liver disease that leads to cirrhosis and need for liver transplantation in a high proportion of cases. The disease occurs in approximately 1 per 100,000 population per year, usually presents in adulthood, and affects men more often than women.

Richard K. Sterling – 29 August 2006